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Design (EuGeneCiD) and modeling (EuGeneCiM)
tools: Computational approach to synthetic biology
Wheaton L. Schroeder,1,2 Anna S. Baber,2,3 and Rajib Saha1,2,4,*
SUMMARY

Synthetic biology has the potential to revolutionize the biotech industry and our
everyday lives and is already making an impact. Developing synthetic biology applications requires several steps including design and modeling efforts which may
be performed by in silico tools. In this work, we have developed two such tools,
Eukaryotic Genetic Circuit Design (EuGeneCiD) and Modeling (EuGeneCiM),
which use optimization concepts and bioparts including promotors, transcripts,
and terminators in designing and modeling genetic circuits. EuGeneCiD and EuGeneCiM preclude problematic designs leading to future synthetic biology
application development pipelines. EuGeneCiD and EuGeneCiM are applied to
developing 30 basic logic gates as genetic circuit conceptualizations which
respond to heavy metal ions pairs as input signals for Arabidopsis thaliana. For
each conceptualization, hundreds of potential solutions were designed and
modeled. Demonstrating its time-dependence and the importance of including
enzyme and transcript degradation in modeling, EuGeneCiM is used to model a
repressilator circuit.
INTRODUCTION
Synthetic biology is the design of living systems, utilizing engineering principles, to accomplish a desired task
or purpose (Khalil and Collins, 2010). To date, applications include novel biochemical synthesis pathways and
many biological analogs of electronic circuits such as logic gates, sensors, toggles, oscillators, and switches
(Khalil and Collins, 2010; Kim and Winfree, 2011; Liu and Stewart, 2015; Scheller et al., 2020) with a long
term goal of programmable biology (Xia et al., 2019). Commercial products which are the result of applications
of synthetic biology are emerging in restaurants (the Impossible Burger), pharmacies (Januvia indicated for
diabetes), electronics (Hyaline used in foldable smartphones), and hospitals (Kymriah, a cell-based therapy
indicated for B-cell acute lymphoblastic leukemia) highlighting the emerging roles of synthetic biology
throughout society (Voigt, 2020). Therefore, the tools which aid in the development of novel synthetic biology
applications will be of both scientific and commercial value to accelerate the development of new
applications. There are five major stages in the development of a new synthetic biology application: Conceptualization; design modeling; construction; probing, testing, and validation (Liu and Stewart, 2015). As a first
step toward creating a synthetic biology application pipeline from a user-defined conceptualization, the
design and modeling steps of this workflow will be explicitly linked in this work using two novel deterministic
in silico optimization-based tools which can be largely automated.
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Particularly in the design of new applications, synthetic biology often relies on the intuition of biologists
and engineers; their knowledge of available promotors, genes, terminators, transcripts, enzymes, and proteins (collectively, bioparts) and the associated systems; and their design ability to create new applications.
This approach is generally limited to system experts and to designs which are intuitive. Alternatively, a
computational model-driven approach is advantageous in that it allows for non-intuitive designs and the
quick in silico screening thereof, so that only designs with the greatest chance of success are constructed.
Several design and modeling tools exist, such as Cello 2.0 (Chen et al., 2020), OptCircuit (Dasika and Maranas, 2008), the work of Zomorrodi and Maranas (2014) (the tool was unnamed), EQuIP (Davidsohn et al.,
2015), SynBioSS (Hill et al., 2008), and several others which may be adapted to various systems and to
screening of genetic circuits (Liu and Stewart, 2015). Figure 1 summarizes the unique approach to the problem of design along with advantages and disadvantages of each of these tools within the context of
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Figure 1. Steps of synthetic biology application development and some in silico tools
Synthetic biology applications generally have five steps: Conceptualization, design, modeling, construction, and
probing, testing, and validation. Of these steps, three can be performed in silico. Several independent design and
modeling tools exist for the second and third stages of this workflow, including Cello, the work of Zomorrodi and Maranas
(2014) (in addition to their previous OptCircuit), and EQuIP. Introduced here are the EuGeneCiD and EuGeneCiM tools
which integrate the design and modeling steps as design solutions are passed from EuGeneCiD to be modeled by
EuGeneCiM. For the listed tools, a short list of strengths and weaknesses is included to help better position this work in
the context of the current state of the field.

developing synthetic biology applications. Although these tools have successfully designed or simulated
behaviors replicated in vivo, the most overarching challenge associated with these tools is their specialization for design or modeling tasks with no clear workflow or method by which to link the two activities. This is
highlighted in that some design tools, such as Cello 2.0, published synthetic biology workflows which skip
the modeling step altogether and used more expensive and time-consuming in vivo screening processes
(Borujeni et al., 2020). A particularly difficult problem in current optimization-based design tools such as
Zomorrodi and Maranas (2014), and OptCircuit (Dasika and Maranas, 2008) are Bistable Orthogonal Designs (BODs). These produced design solutions that would not function as desired. For instance, consider
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Figure 2. Example bistable orthogonal design (BOD)
This figure illustrates a major category of problematic potential designs which may be produced by optimization-based genetic circuit design tools. From a
conceptualized Cu2+/Zn2+ responsive AND circuit, it is possible, without attribution equations, to create Bistable Orthoganol Design (BOD) which can
produce the desired response, yet not be responding to the desired signals. Text in the image describes why this occurs. One of the major innovations in
EuGeneCiD is the development of attribution equations to avoid BODs.

the example shown in Figure 2, where it is desired to produce a circuit with an AND response to copper and
zinc ions using a GFP reporter. Using only a handful of parts, it is possible to produce a circuit with two stable states (where both tetR and GFP are produced or only cI is produced). Further, these two stable states
are independent of (or orthogonal to) the signals which the circuit should respond (e.g., the copper and
zinc ions). For such a BOD, a solver might then pick whichever state is necessary to match the desired
conceptualized circuit behavior irrespective of the conditions, rendering the circuit effectively useless for
the proposed application. These BODs are technically correct solutions to the conventional optimization-based tools but require further manual scrutiny to identify and remove these problematic solutions.
When producing large numbers of solutions, BODs generally outnumber true designs and can overwhelm
a researcher’s ability to screen.
One promising area for synthetic biology applications is in plants, particularly commercially important
crops such as maize (Zea mays), rice (Oryza sativa), and barley (Hordeum vulgare). Applications in plants
include increasing nutrient content (Beyer et al., 2002; Gonzali et al., 2009), synthesizing novel chemicals
(Liu and Stewart, 2015; Mortimer, 2019), improving crop resilience (Pixley et al., 2019), and synthetic sensors
(Liu and Stewart, 2015). Here, we have chosen to demonstrate our novel tools using the model plant species
Arabidopsis thaliana (hereafter, Arabidopsis) because it is well studied and has been used for many synthetic biology applications (Holland and Jez, 2018). We have further chosen to design and model plantbased synthetic sensors of heavy metal in the root of Arabidopsis. Heavy metal pollution occurs as a result
of human activities (such as mining or manufacturing), and is toxic to living organisms at sufficient concentrations, even essential elements such as Zinc. These metal ions can enter the soil via several possible routes
including from water and the air (Vardhan et al., 2019; Vareda et al., 2019). Three of the most common heavy
metal pollutants are Copper, Cadmium, and Zinc (Vardhan et al., 2019), to which Arabidopsis has some natural response mechanisms. By creating reporter systems which respond to these heavy metal ions, it may
be possible in the future to develop synthetic biology applications in crop species for metal ion removal or
mitigation from contaminated soils through phytoremediation (Jacob et al., 2018). Different logical combinations of present ions might require different phytoremediation strategies; therefore, the construction
of logic gates responding metal ion signals would be a logical first step in the long-term development of
these strategies and applications.
For developing a combined design and modeling workflow, in this work, we developed two deterministic
optimization-based tools, namely the Eukaryotic Genetic Circuit Design (EuGeneCiD) and Modeling (EuGeneCiM) tools, which utilize an input of the conceptualized circuit behavior and perform an automated
simulation of the optimal and suboptimal circuit designs for manual screening. EuGeneCiD provides
one key improvement upon previous optimization-based tools (Zomorrodi and Maranas, 2014; Dasika
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and Maranas, 2008) by developing constraints (called the attribution constraints) which precludes BODs. In
addition, several other distinct differences and improvements distinguish the EuGeneCiD tool from either
of these previous works. First, EuGeneCiD is designed for eukaryotic systems where Ribosome Binding
Sites (RBSs) are not a critical design element, but replaces such elements with terminators which are important in eukaryotic gene expression, particularly for plants (de Felippes et al., 2020; Nagaya et al., 2010). Second, the rate of mRNA and protein degradation on circuit behavior is incorporated, which leads to new
design possibilities. Third, the tool was made more granular so that concentration values are not always
integer values. Fourth, the layers of the central dogma (transcription and translation) are mathematically
separated so that, aside from relative concentration levels, relative levels of mRNA for genes might also
be designed and simulated. EuGeneCiM takes these unique elements and, utilizing a design passed
from EuGeneCiD, simulates circuit behavior over a given number of hypothetical time points, which will
allow for screening of circuit behavior before constructing these proposed synthetic biology applications.
Using bioparts, which are either a part of natural Arabidopsis heavy metal response mechanisms, or shown
to function in Arabidopsis from other species, and fluorescent proteins as state reporters, EuGeneCiD is
applied to developing these synthetic heavy metal sensors in Arabidopsis. EuGeneCiD was used to create
design solutions for 30 different genetic circuits formed from combining nine unique two-input logic gates
with three different input signal pairs. These input signals are the presence of Cadmium, Copper, and Zinc
ions at high or toxic concentrations. For each genetic circuit conceptualization which was able to be designed from the given biopart library, EuGeneCiD generated hundreds of feasible solution designs,
each with a corresponding dynamic simulation from EuGeneCiM. Aside from basic logic circuits, repressilators have also proven to be a useful control schema in synthetic biology, allowing for oscillating gene
expression (English et al., 2021). Therefore, EuGeneCiM is used to model the dynamic behavior of a repressilator circuit to demonstrate its utility as a stand-alone dynamic modeling tool and the value of incorporating mRNA and protein degradation in modeling efforts. Together, the EuGeneCiD and EuGeneCiM
tools can hypothesize genetic circuit designs and simulate their behavior to increase the chances that a
plant might have the desired behavior when transformed, potentially saving time and resources. This
work could be the basis for the development of a synthetic biology application pipeline. Therefore, for
the ease of use and the facilitation of this pipeline, various programs have been developed to make EuGeneCiD and EuGeneCiM user-friendly, and a related protocol paper on the use of these tools will be published to accompany this work. Further, the design solutions produced here could form the basis of future
heavy metal phytoremediation applications of synthetic biology particularly in important crops like Zea
mays (maize). Maize has been identified as both Cadmium tolerant (Rizwan et al., 2017) and as a Cadmium
hyperaccumulator (Wuana and Okieimen, 2010), and is already used for heavy metal phytoremediation
(Rizwan et al., 2017). Additionally, maize has been identified as a bioaccumulator of both Zinc and Copper
(Sekara et al., 2005; Wuana and Okieimen, 2010). From this, maize is already particularly well suited for phytoremediation applications, and could be engineered through synthetic biology to be superb, solving multiple problems at a stroke by providing food from otherwise toxic farmland while cleansing it of heavy metal
ions toxic to both humans and other plants.

RESULTS
Selection of test system and synthetic biology conceptualizations
Arabidopsis was chosen as the test system for the development and subsequent application of the EuGeneCiD tool since it is a model plant system to which systems biology has often been applied (Holland and
Jez, 2018). It was decided to develop heavy metal ion biosensors in the Arabidopsis root, which would
report sensor state using fluorescent proteins. A plant system, in particular, was chosen for this work
because in the future EuGeneCiD and EuGeneCiM will be applied to plants of biotechnological and agronomic importance (e.g., Zea mays) for various applications related to plant health and fitness, potentially
including phytoremediation of heavy metal pollution. Since phytoremediation strategies may change depending on the metal ion(s) present, basic logic gates are conceptualized here which report on the presence or absence of the metal ions.

Development of the Eukaryotic Genetic Circuit Design (EuGeneCiD) tool
EuGeneCiD was conceived and developed to address the limitation of the current state-of-the-art optimization-based design tools for synthetic biology applications (Zomorrodi and Maranas, 2014; Dasika and
Maranas, 2008). Particularly, by changing the focus to eukaryotic systems, allowing granularity, modeling
transcript abundance, adding terminators as a design element (which are particularly important in plant
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synthetic biology), and creating the attribution constraints. The initial EuGeneCiD formulation was inspired
by other optimization-based circuit design works (Ali R Zomorrodi and Maranas, 2014; Dasika and Maranas,
2008) and was formulated specifically to apply to eukaryotic systems and incorporate biopart degradation.
This involved using terminators, as opposed to RBSs, as part of the design; incorporating mRNA and protein degradation; having a more granular values of concentration; and reporting relative mRNA abundance
for particular genes. Attempts were made to incorporate time to make EuGeneCiD a dynamic design tool.
This would influence various design variables, such as concentration, yet this proved computationally
intractable and was abandoned. At this stage in development, it was decided to separate the formulations
of design and modeling tools. When applying this first version of the EuGeneCiD tool to a modest sized
biopart database, the issue of BODs became apparent and pressing. The final stages of the development
of EuGeneCiD involved the creation of the attribution constraints to prevent BODs. These attribution constraints account for a high fraction of all constraints (about 42%) and variables (about 42%) in the formulation of EuGeneCiD and thus account for a fair amount of the tools’ computational expense. This tradeoff is
considered worthwhile in that it allows for the preclusion of BOD solutions which can account for greater
than 90% of solutions in some instances when the attribution equations are not included. The final formulation of EuGeneCiD is a Mixed Integer Linear Programming (MILP) problem, with a single-level objective
function maximizing the concentration of desired enzymes and minimizing that of undesired enzymes.
Initial testing of both EuGeneCiD and EuGeneCiM was conducted using hypothetical bioparts, details
of which are provided in the GitHub repository associated with this work (github.com/ssbio/
EuGeneCiDM or https://doi.org/10.5281/zenodo.4762590). The final formulation has over three dozen
constraints and variables which are detailed in the STAR Methods section.

Development of the Eukaryotic Genetic Circuit Modeling (EuGeneCiM) tool
EuGeneCiM was conceived and developed to address the lack to optimization-based tools for the
modeling of proposed synthetic biology application designs, particularly one which might readily be
passed designs for screening. As previously stated, EuGeneCiM initial development began when it was
noticed that including time-based simulations inside the EuGeneCiD tool was computationally intractable.
EuGeneCiM is similar to EuGeneCiD in formulation with three major exceptions. First, the design variable is
made a parameter in EuGeneCiM as these values are passed from an optimal or suboptimal solution of
EuGeneCiM. Second, as EuGeneCiM does not design, the attribution constraints are unnecessary and
therefore unused, thus considerably boosting solution speed. Third, as the design is not variable, this allows certain simplifications in the formulation. The final formulation has approximately two dozen constraints and variables which are detailed in the STAR Methods section.

Initial testing of the EuGeneCiD and EuGeneCiM tools
Initial testing of both EuGeneCiD and EuGeneCiM was conducted using a test bioparts database and test
codes, provided in the GitHub repository associated with this work (github.com/ssbio/EuGeneCiDM). This
test bioparts library consists of 33 promotors, 13 transcripts, 10 terminators, and 13 proteins and enzymes.
Versions of the EuGeneCiD and EuGeneCiM workflow were created which allow for one-, two-, and threeinput circuit designs. These circuits include the following logics: ADDER (three inputs), AND (two inputs),
BUFFER (one input), HALF ADDER (two inputs), NAND (two inputs), NOR (two inputs), NOT (one input), OR
(two inputs), XNOR (two inputs), and XOR (two inputs). Through these tests, numerical issues such as BODs
were discovered. The final EuGeneCiD and EuGeneCiM workflow was not applied to these test circuits and
database, though these test applications show that EuGeneCiD and EuGeneCiM can be adapted to circuits with other than two input signals.

Definition of the bioparts database
Following the creation and initial testing of the EuGeneCiD and EuGeneCiM tools, a database of real bioparts was created for the design of genetic circuits which respond to Cadmium (Cd2+), Copper (Cu2+), or
Zinc (Zn2+) ions, or combinations thereof to design and simulate various logic gates. Note that bioparts
which are responsive to the metal ions do not directly respond to those ions, but rather make use of the
native metal sensing or signaling pathways of Arabidopsis and are bioparts whose activity is affected by
these signaling pathways. This approach is used because it was decided that it would be too complex
to introduce the various signal pathways in a target organism with each design. Promotors included in
the biopart database are shown in Figure 3. Details on the sources for these bioparts, their parameterization, and their reason for inclusion in the database can be found in Table S1.

iScience 24, 103000, September 24, 2021
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Figure 3. Bioparts database for the current work
The EuGeneCiD and EuGeneCiM Tools designed require the definition of bioparts databases from which to pick design elements
and to define the properties of those elements for both design and modeling. For compactness in other images, introduced here
is a shorthand for promotor, transcript, terminator, and protein characteristics. The shorthand here is then used to define each
biopart included in the bioparts library used for this work, which includes promotors, transcripts, terminators, and proteins. Source
species acronyms for listed bioparts are as follows: Ath –Arabidopsis thaliana, Osa –Oryzae sativa, Eco –Escherichia coli, Vco –
Verrillofungia coninna, Avi –Aequorea victoria, Atu–Agrovacterium tumefaciens, Cmv–Califlower Mosaic Virus.

Application of EuGeneCiD and EuGeneCiM
The EuGeneCiD and EuGeneCiM tools are embedded in the workflow shown in Figure 4. In summary, this
workflow uses the bioparts library and the synthetic biology application conceptualization as inputs from
which the EuGeneCiD problem is attempted. Should a solution be found, EuGeneCiM is solved across
several time points to model the designed circuit. If a solution is not found, there are two possibilities:
all possible designs with the specified parameters (primarily circuit size) have been identified, or that all
possible designs have been identified which are smaller than some maximum allowed circuit size. In the
former case, the size of the sought design is incremented, and EuGeneCiD is attempted again. Otherwise,
the selection of designs is returned, and the user may select a design from the design and modeling information. For greater details, see STAR Methods.
To demonstrate the utility of EuGeneCiD and EuGeneCiM tools, it was decided to use these tools to design
and model 30 unique genetic circuit conceptualizations using the defined real bioparts database. Each
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Figure 4. Workflow of the EuGeneCiD and EuGeneCiMtools
The EuGeneCiD and EuGeneCiM tools were designed to be used in concert to complete the design and modeling steps of synthetic biology applications
development together. This workflow begins with a defined conceptualization of the application (in the form of a logic table) and a bioparts library which
defines and describes potential design elements (see Figure 2). Then an attempt to solve EuGeneCiD is made, with three possible outcomes. First, no
solution is found at the current design size limit (limiting the number of allowed triads), in which case this limit is incremented, and EuGeneCiD is attempted
again. Should design or run limits be reached, or if no further designs exist within specified restrictions, the set of designs is returned which can be manually
screened for candidates likely to succeed. Should the attempt to solve EuGeneCiD be successful, a circuit design is the result, which is passed to EuGeneCiM
for modeling. This modeling solves EuGeneCiM at each time point and applies protein and transcript degradation between time points for the full set of
desired model time points. This results in a simulation of design behavior at each time point which will be reported. The current solution is then precluded by
defining a new integer cut and the cycle is repeated.

conceptualization will have its own input file; an example is provided in Table S2, containing all information
from Table S1 in addition to a logic table, and a parameter specifying the number of time points to model.
These unique conceptualizations were defined both by the logic circuit and the ligand pair to which that
circuit is to respond. The logic circuits to which EuGeneCiD and EuGeneCiM were used to design and
model include BUFFER (also known as a toggle circuit), AND, NIMPLY, converse non-implication (abbreviated CNI), HALF ADDER, NAND, NOR, OR, XNOR, and XOR. Note that CNI is included because it is logically equivalent to NIMPLY with a reversed ligand order. Further, this study does not purport to study all
possible or useful logic gates, but rather these 30 conceptualizations will show the usefulness of the EuGeneCiD and EuGeneCiM workflow to apply to a variety of genetic circuit conceptualizations. Divalent heavy
metal ion pairs, representing common heavy metal pollutants (Vardhan et al., 2019), were selected to serve
as the signals for the logic gates by their presence or absence. The metal ion signal pairs used are Cadmium
and Copper; Cadmium and Zinc; and Copper and Zinc. The number line shown in Figure 5 shows each combination of metal ion signal and logic gate.
It should be noted that the applications of EuGeneCiD and EuGeneCiM when applied to the real bioparts
database do not make full use of the in-built capabilities of these algorithms. First, these algorithms have
the potential to consider alternative splicing, through definitions of the variable which maps transcripts to
its encoded enzyme (rje ) and transcriptional efficiency (hj ). The former can be used to define more than one
transcript-enzyme encoding relationships and the latter can be lowered to reflect fractions of transcript being used to encode each alternative splice. In addition, the capability exists for enzymes to be regulated by
environmental cues and other enzymes. These capabilities are not exploited in this application because it
was desired to apply these tools to a plant system, and Arabidopsis appears to not have such sophisticated
bioparts natively (at least for heavy metal signaling and resonse pathways), nor have such parts been engineered for Arabidopsis. However, these capabilities will function in the event that they are needed
and defined in the input bioparts library, as these functions have been tested using the test database
described earlier.

General EuGeneCiDsolution trends
Several general trends emerge from the sets of solutions produced by EuGeneCiD and can be identified in
Figure 5. First, as highlighted in Figure 5, using the given database, it appears that certain simpler logic
gates such as BUFFER, AND, NIMPLY, NOR, and OR are easier to find design solutions for. This is indicated
by high numbers of solutions after the seven day run time, short solution times (minimum, average, and
maximum), and a large percentage of reported solutions being proven optimal solutions (as opposed to
integer solutions which do not guarantee optimality). On the other hand, circuits such as XNOR, XOR,
and HALF ADDER are generally more difficult to find design solutions as indicated by fewer solutions,
longer solve time, and low percentage of reported solutions being proven optimal. For these circuits,
the majority of solutions are integer solutions without proven local or global optimality. In addition, these
more difficult circuits generally also have higher minimum and mode circuit sizes, as well as longer solution
times. These circuits are also more likely to have been terminated by reaching the seven day time limit, as
opposed to the easier circuits which were more likely to be terminated by reaching the maximum number of
allowed solutions. As shown in Figure 5, more complex solutions generally require more triads (solution
size is reported as the number of triads in the design) to achieve the desired logic.
A particularly interesting trend in EuGeneCiD solutions, shown in Figure 5, is that the maximum objective
function value rarely occurs in the first solution, with the exception of the Cu2+/Zn2+ XOR and Zn2+ BUFFER
responsive circuits, though the minimum objective value sometimes occurs at this point. This can be for
multiple reasons. The objective function is defined as the difference of response strength under desired
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Figure 5. Visualized holistic EuGeneCiDresults
Thisfigure highlights several key result metrics of the application of EuGeneCiD to a large number of synthetic biology
application conceptualizations seeking a large number of solutions. Each bar indicates the minimum, mean, and maximum
solution time for specified inputs (indicated by color) and logic gate (indicated by the logic gate drawing on the bar). The
number to the right of the bar indicates the number of solutions achieved, and the pie chart to the right of the bar indicates
what percent (rounded to the nearest whole percent) of those solutions were proven to be globally optimal. To the left of the
bar are given the solution size (in number of triads in each design) statistics, formatted as ‘‘min/max (mode)’’. Above the legend,
which defines the symbols and colors used, is given the characteristics of the database used to derive these solution sets.

response conditions and response strength under undesired condition. This formulation ideally will favor
solutions with strong responses and low expression leakiness. See STAR Methods for the mathematical
formulation. The first possibility is that a biopart with this inherent function might be leaky or not particularly strong, yet would be the simplest possible solution. A second possibility is, due to the nature of the
EuGeneCiD objective function, different circuit conceptualizations will have slightly different priorities in
their optimal designs. In summary, depending on the sparsity of the response vector(s) in the input logic
table, a slight favoritism for low leakiness of the response protein(s) or for a strong response pulse may
be favored. A full discussion of this can be found in the STAR Methods.
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Dissecting selected circuit designs
This study produced a very large number of design and modeling results, more than 23,000 to be precise. This
volume allows for analysis of the broad solution trends discussed while precluding the analysis of each individual solution. All solutions may be found in the associated GitHub repository (github.com/ssbio/
EuGeneCiDM). Additionally, code is provided in the repository which will plot any given solution (see the provided documentation in GitHub). This code was used in part to generate the graphs in Figures 6 and S4
(showing example BUFFER solutions). By investigating several solutions using this code, we have selected
three representative circuit results (two of which could be defined as likely to be successful and one is unlikely
to be successful) as example results, shown in Figure 6. One general feature of interest in the EuGeneCiM tool
can be seen in each of the modeling results graphs: the start-up time. EuGeneCiM essentially assumes that the
genetic circuit is newly introduced into the target organism at time point 0; therefore, there is some delay
(2 time points) between introduction of the circuit and the response of the circuit to environmental conditions.
This delay is caused by the enforced delays in the EuGeneCiM algorithm. The first enforced delay is between
transcription and translation (allowing for phenomena such as time for RNA processing and transport). The
second is between translation and protein activity (allowing for phenomena like protein folder and localization). A second point of interest is that, while both tools use Mixed Integer Linear Programming, the curves
produced are non-linear. This is because, in EuGeneCiM, the half-life based degradation of transcripts and
proteins is calculated between time steps as a ‘‘carry over’’ value from one time point to the next (as shown
in the workflow image Figure 4 and described in the STAR Methods).
The first successful example, solution #41 for a Cd2+/Cu2+ responsive AND circuit, is shown in the top third
of Figure 6. Solution #41 was chosen as it is the Cd2+/Cu2+ responsive AND circuit with the maximum objective function value, likely due to the multiple gated encoding of GFP. This solution contains four triads (promotor/gene/terminator groupings which specify the circuit design): PFRO2/gene_cI/HSPt, Para/gene_cI/
CaMV25St, PRM/gene_GFP/HSPt, and PEXO70B1_11/gene_GFP/HSPt. There are two responsive elements
to the signal ions, promotors PFRO2 (responding to Cd2+) and PEXO70B1_11 (responding to Cu2+). These
then regulate the expression of GFP indirectly and directly, respectively. Note that while Para is regulated
by araC, because araC is not encoded, it will act like a constitutive promotor. Due to the short half-life of cI,
this circuit maintains a constitutive pool of cI which is below the concentration threshold necessary for a cIexpressing phenotype unless Cd2+ is present. This gates the expression of GFP from the PRM/gene_GFP/
HSPt triad, preventing GFP expression from this triad unless Cd2+ is present. GFP expression induced by
Cu2+ is regulated directly. This causes the circuit to be quicker to respond to the presence of Cu2+ than to
Cd2+ in the modeling results. The double-encoding of the GFP results in the significantly stronger response
of the circuit to both conditions, than to a single condition. This is one potential drawback of the binary
encoding of the conceptualization in that there is no mechanism to ensure equal expression in all cases
where expression is desired, since phenotype is what is desired, rather than strength of that phenotype.
The second successful example, solution #11 of a Cu2+ NIMPLY Zn2+ circuit, is shown in the middle third of Figure 6 also uses cI as the desired control enzyme which gates expression of GFP. This circuit uses three triads in
the design: PGSTF1/gene_cI/HSPt, PFDR3/gene_cI/NOSt, and PRM/gene_GFP/HSPt. For controlling the expression of cI, a moderately strong promotor, PFDR3 (which is repressed by Zn2+), is paired with a relatively inefficient
terminator NOSt, which results in a pool of cI transcripts which can quickly build or degrade in the absence or
presence of Zn2+ but which is not sufficient for cI-expression phenotype. The PGSTF1/gene_cI/HSPt triad then is
also a deciding factor in cI phenotype, encoding stable RNA (from an efficient terminator, HSPt) from a moderate promotor (PGSTF1). This second promotor results in a slowly building yet stable pool of cI transcripts.
When both triads produce cI, the concentration is high enough for cI expression. When cI is expressed, the
very strong promotor PRM is activated, resulting in strong GFP expression. When modeled, this mixed approach
to cI production (using from quick- and slow-accumulating pools of cI transcript) in combination with the sort
half-life of cI results in a slow-responding circuit (only beginning to diverge from other conditions at time point
7), as expression from both triads is required. Yet, when cI is at sufficient concentration, the circuit responds very
strongly. It is highly possible that the response strength would be greater than what is shown if the circuit were
modeled for more time points. Theoretically, this circuit could be quickly ‘‘shut off’’ by lack of a Cu2+ signal or
especially the presence of a Zn2+ signal. Due to the single-encoded gene_GFP, GFP expression is uniform and
low in non-expressive conditions.
The provided unsuccessful solution is solution #26 for a Cd2+/Zn2+ responsive NAND circuit, shown in the
bottom third of Figure 6. As with the previous example, three triads are used, two of which gate the
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Figure 6. Example EuGeneCiD and EuGeneCiMsolutions
Shown here are three circuit conceptualizations, EuGeneCiD design solutions, and their associated EuGeneCiM models.
The conceptualization is shown as the input logic table. The solution is shown with the design triads and produced
enzymes with regulatory relations shown (green for activation, red for inhibition), including their relative strengths (shown
as numbers on top of the regulation line). The modeled design responses are shown in the rightmost panel; where purple
squares indicate the presence of both signals; blue circles and red crosses denote only one signal (see individual
legends); and gray plus signs indicate no signal. Of the provided solutions, two of were shown to be potentially successful
(Cd2+/Cu2+ OR circuit solution #41 and Cu2+ NIMPLY Zn2+ circuit solution #11) and one shown to be potentially
unsuccessful (Cd2+/Zn2+ NAND Circuit solution #26) by EuGeneCiM.

expression of GFP through a control enzyme, in this case, araC. The triads of this design are PCdI3/gene_araC/CaMV25St, PHYP1/gene_araC/NOSt, and Para/gene_GFP/HSPt. One interesting point to note is
that the used promotors are weaker and terminators are less efficient than those generally used with cI
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because the control enzyme, araC, has a longer half-life. In this unsuccessful example, the circuit responds
correctly to the presence of both Cd2+ and Zn2+; of Zn2+; and to no signal. This circuit fails in the condition
at which only Cd2+ is present. This is because, while EuGeneCiD partially accounts for enzyme degradation,
it does not account for accumulation as it predicts that under this condition araC will not accumulate sufficiently to be active. However, when accounting for accumulation, EuGeneCiM predicts that araC will accumulate enough for an araC-expressed phenotype around time point 5, resulting in a sharp decline in GFP
response from this point. This circuit could be potentially corrected by replacing the terminator in the PCdI3/
gene_araC/CaMV25St triad with a less efficient terminator. Unlike the other examples, this also illustrates
that the trend of EuGeneCiM models might change direction and even sign during the simulation. This
change during the simulation may result in a correct circuit response, whereas previous time points might
suggest an incorrect response (consider the condition where both Cd2+ and Zn2+ are present). This suggests that for some circuits it may be useful to look at longer-term behavior in some cases where a designed
circuit may be modeled to show an incorrect response.

EuGeneCiM-modeled repressilator
To demonstrate the utility of EuGeneCiM as an independent modeling tool, it was decided to model a repressilator circuit. Repressilator circuits rely on the degradation of proteins whose expression is repressed
to allow a downstream protein to be expressed, and therefore could not be modeled by non-dynamic genetic circuit modeling tools, or tools which do not consider transcript or protein degradation. A five-triad
repressilator circuit was manually designed (because a repressilator cannot be designed by the non-dynamic EuGeneCiD) and is shown in Figure 7. This circuit utilizes araC, cI, and tetR control enzymes from
E. coli, which have been reported to be used in synthetic biology applications in Arabidopsis (Messing,
1998), are well characterized, and which control promotor expression. All these enzyme inhibit one promotor in the biopart library, and importantly two of these enzymes have corresponding promotors which they
activate, araC and cI. No promotor could be found which was activated by tetR. These activated promotors
encode reporting fluorescent enzymes mKO (activated by araC) and GFP (activated by cI) identified
through the fluorescent protein database (fpbase.org). Using EuGeneCiM, it was decided to model the first
100 relative time points of the simulation of the repressilator.
This simulation highlights several important features of the EuGeneCiM for which there was no opportunity
for discussion when modeling EuGeneCiD-created designs. First, transcript production, transcript level
(shown in Figure 7C), enzyme production, and enzyme level (shown in Figure 7B) are all modeled and
tracked by EuGeneCiM (complete results can be found in the GitHub associated with this work at
github.com/ssbio/EuGeneCiDM). Second, the shape of the response curves is of interest. As shown best
by the tetR response curve (purple), EuGeneCiM models can achieve steady state (or near steady state)
and be perturbed from that state. This curve also shows that EuGeneCiM is capable of modeling oscillatory
circuit designs. This indicates that EuGeneCiM is not wholly dependent on EuGeneCiD and can be used as
an independent modeling tool. Further, upon introducing three enzymes, there is some unsteady-state
start-up period where the enzymes in question are all produced prior to some control enzyme taking dominance. Using GFP as an example, this period is approximately the times from time points 0 to 12. This is the
start-up period, and varies to some extent between enzymes, though it appears that GFP has the longest
such period. It can also be seen in these graphs that the amplitude of enzyme responses are uneven between enzymes. This is due to differences in promotor strength (stronger promotor, higher peak), terminator efficiency (more efficient terminator, higher peak), and enzyme half-life (longer half-life, higher
peak). These factors also influence the breadth of the peaks, with shallower peaks also being broader,
and taller peaks being narrower, with cI and GFP as the two more extreme cases in each direction, respectively. However, it should be noted that regardless of the breadth or height of the peaks, all enzyme expressions have a period of 22 time points, a period which is indefinitely stable (this repressilator has been
modeled out to 500 time points).
One potential discrepancy with in vivo behavior is that repressilator responses in vivo are generally sinusoidal in behavior, in EGeneCiM models, the behavior is not perfectly sinusoidal in shape with sharp
discontinuities at peak and trough. This is because transcription of a triad is modeled as a binary (either
transcribed or not), rather than as a more continuous process as might occur in vivo. However, this wave
has several similarities to a sine wave including a well-defined period (22 time points), amplitude (approximately 8 units), y-intercept (varies depending on the enzyme of interest, for GFP it is 10.37 units, defined
from the average post-start-up), and x-intercept (varies depending on the enzyme of interest, for GFP this is
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Figure 7. Repressilator simulated using the EuGeneCiMtool
While the EuGeneCiD and EuGeneCiM tools were designed to use in concert, they can be used independently, as
evidenced here where EuGeneCiM is used to model a manually-designed repressilator.
(A) Shows the repressilator design with promotors (black), transcripts (green), and terminators (red) (collectively the
design triads) in addition to the transcripts (light purple) and proteins (purple) produced thereby. The shorthand used
throughout this work is used to show the characterization of these parts. Further, regulatory relations are shown (green for
activation, red for inhibition).
(B) Scatterplot showing the dynamic behavior of the enzyme level for each of the enzymes included in the repressilator.
(C) Scatterplot showing the dynamic behavior of the transcript level for each of the enzymes included in the repressilator.

2 units). Despite their slightly different shape, they still are quite similar to sine waves nonetheless. As a
demonstration of the modeled GFP enzyme level’s similarity to a sine wave, a sine wave with the aforementioned characteristics of the GFP expression curve, graphs are provided in Table S3 which highlight the
similarity of the GFP enzyme level curve shape and that of a sine wave. This has also been done for cI.
The Pearson correlations between these curves are r = 0.91 and r = 0.97, respectively, showing a strong
linear relationship between the curves produced by EuGeneCiM and the sine waves produced by using
the characteristics of those curves, suggesting that the shape of the curves are very similar. Further, these
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curves have the same mean value (about 10.4 units), and similar standard deviations (5.7 units for the sine
wave and 6.0 units for the GFP curve) suggesting very similar magnitude, in addition to similar shape.

DISCUSSION
Synthetic biology holds great potential for technological advancements and applications in a wide variety of
fields. The designing of a new application involves five distinct steps, of which the first three (conceptualization,
design, and modeling) can be performed in silico. Designing and modeling synthetic biology applications in
silico holds several advantages including speed, tractability, advantages associated with certain types of mathematics such as optimization, and the potential to develop a pipeline for synthetic biology applications. This has
been recognized by other researchers, who have developed in silico tools for either design or modeling of genetic circuits, which are generally not paired with a complimentary tool in the other step (see Figure 1). This work
seeks to address this lack and work toward pipeline development by explicitly and easily linking the modeling
and design steps, as well as expanding and improving upon optimization-based circuit design algorithms. In
this work, it was decided to design and model plant-based heavy metal ion biosensors in Arabidopsis. These
biosensors were designed to detect Cadmium, Copper, and Zinc, which are common metal ion pollutants,
as a potential basis for future synthetic biology applications for phytoremediation. Arabidopsis was chosen
as a model plant system with many previous synthetic biology applications, and it is eventually intended to apply
EuGeneCiD and EuGeneCiM tools for applications in other plants (e.g., maize).
In the current work, two deterministic optimization-based tools for the design and modeling steps of the
development of synthetic biology applications are introduced, the Eukaryotic Genetic Circuit Design
(EuGeneCiD) and Modeling (EuGeneCiM) tools. These tools together can hypothesize and screen for potential genetic circuit designs which will be most likely to success when built in vivo. The first tool uses inputs
of a bioparts database and a conceptualization of the desired application (in the form of a logic table) to
design hypothetical genetic circuits. This tool is unique compared to previous tools in that it models transcript production; focuses on eukaryotic systems; accounts for transcript and enzyme degradation; and is
more granular in its predictions than previous optimization-based tools. EuGeneCiD is paired with the dynamic circuit modeling tool EuGeneCiM, which uses the EuGeneCiD design and the bioparts databases as
inputs. See Figure 4 for a visualization of the workflow.
Once these tools were developed, they were applied to 30 different systems biology conceptualizations which
were created by pairing a logic gate (BUFFER, AND, NIMPLY CNI, HALF ADDER, NAND, NOR, OR, XNOR, and
XOR) with ligands for that gate to respond to (single ligands for the BUFFER, namely Cd, Cu, and Zn, paired
ligands for the other circuits, namely Cd/Cu, Cd/Zn, and Cu/Zn). These conceptualizations were chosen so as
to make Arabidopsis roots as biosensors for heavy metal pollution, which can eventually be used as a basis
for synthetic biology phytoremediation applications. The combined EuGeneCiD and EuGeneCiM workflow
was run for seven days for each of the 30 conceptualization. The results of all 30 circuits are shown broadly in
Figure 5, with some specific solutions to both EuGeneCiD and EuGeneCiM shown in Figure 6, while those of
much simpler BUFFER circuit are shown in Figure S4. Briefly, EuGeneCiM solves more quickly and with higher
fractions of optimal solutions for simpler circuit logic, for example BUFFER, AND, NIMPLY, and NOR and more
slowly for more difficult logics like XOR, HALF ADDER, and XNOR. As shown in Figure 6, when modeled dynamically, while many EuGeneCiD-created designs functioned correctly, designs did not always function correctly
under dynamic modeling. This showed that EuGeneCiM adds value by screening potentially unsuccessful solutions. This is in part because EuGeneCiD does not design circuits with respect to time, so accumulation of
enzymes and transcripts are not accounted for at the design stage. We also wished to emphasize that the
EuGeneCiM tool could be used as a stand-alone dynamic genetic circuit modeling tool, and to this end,
EuGeneCiM is successfully applied to a manually designed repressilator (see Figure 7). This highlights how
the EuGeneCiM tool crucially accounts for enzyme and transcript degradation allowing modeling of important
dynamic circuits such as repressilators.
As shown in Figure 5, no set of EuGeneCiD solutions for any of the 30 synthetic biology application conceptualizations produced only optimal solutions. For all, some fraction of solutions were integer solutions
with no guarantee of optimality (local or global). The two-input conceptualization with the highest fraction
of optimal solutions is the Cd2+/Zn2+ responsive AND circuit with 84% and that with the lowest fraction is
the Cd2+/Cu2+ responsive HALF ADDER and XOR circuits with slightly less more than 9% of solutions being
optimal. The lack of any conceptualization identifying only optimal solutions has a few possible explanations. The first is that there is some ‘‘best’’ set of solver settings which would achieve only optimal solutions
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which we have not been able to identify. Due to the long run time of some circuit designs (seven days), it
was not deemed worth the time and effort to identify this set. A second possibility is the sheer number of
solutions sought in that the runs were set only to terminate when 1000 solutions had been identified, the
sought circuit size exceeded ten triads, or seven days had passed. A third possibility is that stretches of nonoptimal solutions occur when the optimal solution lies along an edge, and the solutions along that edge are
not globally optimal because equivalent designs exist. As shown in output files such as for the Cd2+ NIMPLY
Zn2+ circuit conceptualization, stretches of sequential non-optimal solutions occur which have the same
objective value (such as solutions #13 through #15), followed by an optimal solution with the same objective
value. In the output of EuGeneCiD, it was found that for the Cd2+/Zn2+ responsive AND circuit, of the 160
non-optimal solutions returned, 81 of these occur in the last 150 solutions identified. Other non-optimal
solutions occur when only a single solution remains at a given circuit size. In some instances, a non-optimal
solution code might also be returned for a solution with the same objective value as an immediately preceding optimal solution (to two decimal points), suggesting that in some cases the non-optimality is inconsequential. Similar patterns occur for many of the easy to solve conceptualizations such as AND, NIMPLY,
and CNI. By this point, a large number of integer cuts have been defined in the model to prevent repeat
solutions, increasing the difficulty of finding a solution. When more difficult, this result in longer run times
and an increased likelihood of heuristic termination from the solver. These heuristic terminators include
lack of improvement on solution bounds in a certain time frame and reaching the maximum allowed
time for a single solution (set at 1 3 104 seconds). These heuristic terminations also might explain the differences between optimality ratios, such as between the Cd2+/Zn2+ responsive AND and Cd2+/Cu2+
responsive HALF ADDER circuits, in that solving the latter is significantly more difficult than the former.
Given the relative positions of optimal to non-optimal solutions, the positions of solutions with the
maximum objective value, and the lengthening solution times at higher solution numbers, for users of
the EuGeneCiD tool it is recommended that only the first 100 solutions need be identified and investigated.
As noted earlier, EuGeneCiD is not a dynamic design tool, although it does attempt to model one half-live
of degradation to attempt to overcome this issue and to include degradation in design criteria. This results
in some design solutions being non-functional under dynamic modeling in EuGeneCiM. EuGeneCiD was
made non-dynamic for one primary reason: computational expense. Given the number of binary variables
inherent in the EuGeneCiD problem, the already long solution times for certain conceptualizations, and the
frequent non-optimality of solutions, it was decided not to create a dynamic EuGeneCiD out of concern for
creating a non-viable tool (or one viable only in niche instances). In future, it is desired to improve the
EuGeneCiD tool, and one of the primary improvements we will aim to implement is to make the tool dynamic, potentially creating a hybrid design and modeling tool. Another issue arising from pairing a static
and dynamic tool such as this, is the cumulative effects of concentration buildup in the dynamic model. This
resulted in the need to halve terminator and enzyme half-lives to attempt to reach similar enzyme production levels in EuGeneCiD as in EuGeneCiM. Without this adjustment, EuGeneCiM predicted levels often
were one to two order of magnitude larger than in EuGeneCiD, resulting in all enzymes in the design being
‘‘active’’ regardless of regulation. This approach to reduce the half-live seemed best to both minimize the
changes the parameters (such as enzyme concentration level thresholds, half-life, transcriptional efficiency,
etc.) and to still produce results on a similar order of magnitude.
Overall, EuGeneCiD and EuGeneCiM have the potential to design with respect to and model biopart interactions which do not exist in the current bioparts database. Some of these functionalities include alternative splicing, changeable transcriptional efficiency (such as might be tuned through codon optimization),
and protein-protein regulatory interactions. In creating a more capable tool, we hope to encompass new
bioparts with sophisticated functionality and regulation which are even now being created by synthetic biologists for fine-tuned control of designed systems. One example is the Two-Component Systems (TCSs)
for phosphoregulated, chemically induced signal transduction in mammalian cells, a work which shows
great potential for the future designs of sophisticated synthetic biology bioparts (Scheller et al., 2020).
In addition to making EuGeneCiD and EuGeneCiM potentially compatible with future synthetic bioparts,
the choice of system and knowledge of that system has limited the biopart interactions which might be present in the library. Arabidopsis was chosen as a test system because it is a model plant to which synthetic
biology applications have previously been applied. A plant system was chosen for the application because,
in future, we hope to use the EuGeneCiD and EuGeneCiM tools to create synthetic biology applications for
Zea mays, particularly those which activate in response to stress conditions to increase plant health and
fitness under these conditions. One potential application is for heavy metal phytoremediation, hence
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the use of heavy metal ligands as signals for designed genetic circuits. Given these desired goals and future
applications, the breadth and types of interactions in the bioparts database was further limited.

Limitations of the study
The EuGeneCiD and EuGeneCiM system essentially applies to a single small cell, as there is no explicit inclusion of transport mechanisms, diffusion, or cell differentiation. Cell differentiation, and the resulting differential expression of genes, in particular must be considered when defining the bioparts database. This
may be problematic when attempting to model behavior in a multi-cellular organism) and has limited ability to account for individual variations between cells. In contrast to other techniques, EuGeneCiD and
EuGeneCiM produce relative concentration predictions, rather than exact levels. Additionally, as already
discussed, while in vivorepressilators have sinusoidal behavior, EuGeneCiM-modeled repressilators due
not due to their underlying binary mathematics, though their shape is similar as already discussed. Further,
some current tools (with a more biophysical focus) include considerations of copy number and phenotypic
ranges, which are not accounted for in the EuGeneCiD and EuGeneCiM tools. As shown in Figure 5, a large
number of returned solutions are non-optimal, particularly for circuit logic which are more difficult to
construct such as HALF ADDER, XOR, and others.
Another limitation of these tools which may be addressed in future is their deterministic nature, as opposed
to a stochastic approach. These tools were developed as deterministic tools for ease of characterization
(e.g., a deterministic model requires no distribution for the generation of ‘‘noise’’), and lower computational cost. While gene expression is often noisy and stochastic in nature, these tools will suffice to design
and model circuit behavior to allow for hypothesizing and screening of potential design solutions. Future
improvements (such as a dynamic EuGeneCiD) may be accompanied by the changing of these tool to be
deterministic.
As no other tool or workflow yet exists which accomplishes both the tasks of modeling and design of genetic circuits from a library of available bioparts, it is difficult to compare this work against that of other
studies. It is of interest to the researchers to confirm the usefulness of the EuGeneCiD and EuGeneCiM
tools with in vivo tests of circuits built from these modeled results; however, it was determined that such
a test is outside the scope of this work.
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STAR+METHODS
KEY RESOURCES TABLE

REAGENT or RESOURCE

SOURCE

IDENTIFIER

www.github.com

RRID:SCR_002630

Perl Programming Language (version 5.26 for Unix)

Perl www.perl.org

RRID:SCR_018313

Strawberry Perl version 5.24.0.1 (for Windows)

Strawberry Perl Strawberryperl.com

RRID:SCR_018313

LWP Meta CPAN

N/A

Deposited data
GitHub
Software and algorithms

The world-wide-web library for Perl, module 6.39

https://metacpan.org/pod/LWP
Comprehensive Perl Archive Network (CPAN)

https://metacpan.org/

RRID:SCR_007253

Generalized Algebraic Modeling System

GAMS Products and Downloads

RRID:SCR_018312

(GAMS) version 24.7.4

www.gams.com/products/buy-gams/

CPLEX solver version 12.6

GAMS Products and Downloads

N/A

www.gams.com/products/buy-gams/
Other
Holland Computing Center: Crane Computing

Holland Computing Center

Cluster (64 GB RAM, Intel Xenon E5-2670

https://hcc.unl.edu/

N/A

2.60 GHz processor, 2 CPUs per node)
ASUSTeKZyphyrus G model laptop computer

Any reasonably up-to-date computer, and

with Microsoft Windows 10.

alternative OSs, will work for this protocol.

Dell OptiPlex 790 desktop computer with

Any reasonably up-to-date computer, and

Microsoft Windows 10 Enterprise

alternative OSs, will work for this protocol.

N/A
N/A

RESOURCE AVAILABILITY
Lead contact
Further information and requests for resources should be directed to and will be fulfilled by the lead contact, Rajib Saha (rsaha2@unl.edu).

Materials availability
This study did not generate new unique reagents.

Data and code availability
The published article does not include all datasets and code generated or analyzed during this study. All
datasets and code generated during this study are available at GitHub in the ssbio/EuGeneCiDM repository [https://doi.org/10.5281/zenodo.4762590] or at the following URL github.com/ssbio/EuGeneCiDM.

METHOD DETAILS
Symbols used
This section is provided here to increase clarity of the provided equations which follow. For the purposes of
this text, a set is an unordered collection of distinct elements, a parameter is a value which is constant during the solution process whereas the value of a variable is altered by the solver to identify optimal solutions.

Sets.
Ahset of all molecules
P 3 Ahset of promotors
J 3 Ahset of transcripts
E 3 Ahset of enzymes
iScience 24, 103000, September 24, 2021
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Ed 4 Ehset of enzymes which it is desired for the circuit to respond to
L 3 Ahset of ligands

Ld 4 Lhset of ligands which it is desired for the circuit to respond to note that
this should always contain a noneÞ
T 3 Ahset of all terminators
Rhset of real numbers
R + hset of nonnegative; real numbers
R hset of nonpositive; real numbers
B h binary set; contains only the numbers 1 and 0; e:g: B = f0; 1g
T h trinary set containing only the numbers  1; 0; and 1; e:g: T = f1; 0; 1g
Parameters.
leL1 L2 ˛ Bhinput logic matrix value for enzyme e under conditions of
ligands L1 ; L2 ˛Ld present
Zp ˛ Bhnormal state of promotor p˛P
ze ˛ Bhnormal state of enzyme e˛E
Ipa ˛ ThEffects of a˛A as a ligand upon the activity of promotor p˛P
ð  1 inhibition; 0 no effect; 1 activationÞ
Hpa ˛ R + hstrength of interaction between promotor p˛P and molecule a˛A
Bea ˛ ThEffects of a˛A as a ligand upon the activity of enzyme e˛E
ð  1 inhibition; 0 no effect; 1 activationÞ
Qea ˛ R + hstrength of interaction between enzyme e˛E and molecule a˛A
V = 1E4han arbitrarily large number
ε = 1E  4han arbitrarily small number
qe ˛ R + hconcentration threshold at which the enzyme e˛E must be present
to be said to be }active}
hj ˛ R + htranslational efficiency of transcript j˛J
Fp ˛ R + hleakiness of a promotor p˛P
Gt ˛ R + hhalf  life of terminator t˛T
t e ˛ R + hhalf  life of enzyme e˛E
sa1 a2 ˛ Bhvalue of 1 if a1 ˛A is the same as a2 ˛A and zero otherwise; identifies
equivalent elements
Sp ˛ R + hstrength of promotor p˛P
Variables.
apL1 L2 ˛ Rhinteger net effect of all inhibition and activation on a given promotor p

˛P under conditions of ligands L1 ; L2 ˛Ld present > 0 promotor can be active

% 0 promotor cannot be active
+
apL
˛ Bhbinary net effect of ligands upon promotor p˛P in circuit under
1 L2


ligand conditions L1 ; L2 ˛Ld 1 promotor can be active; 0 promotor cannot be active
geL1 L2 ˛ Rhinteger net effect of all inhibition and ativation on a given enzyme e
˛E under ligand conditions L1 ; L2 ˛Ld ð>0 enzyme can be active; % 0 enzyme cannotÞ
+
˛ Bhbinary net effect of ligands upon enyme e˛E in circuit under ligand
geL
1 L2
conditions L1 ; L2 ˛Ld ð1 enzyme can be active; 0 enzyme cannot be activeÞ
4jtL1 L2 ˛ R + hlevel of transcript j expression under ligand conditions L1 ; L2 ˛Ld
Mpjt ˛ Bhbinary variable which creates promotor p˛P; transcript j˛J; and

terminator t˛T triads representing the design variable in EuGeneCiD;


parameter in EuGeneCiS
CeL1 L2 ˛ R + hconcentration of enzyme e˛E under under ligand conditions L1 ; L2 ˛Ld
xpjtL1 L2 ˛ R + hdeliberate transcription of j˛J transcribed from promotor p˛P
and transcript t ˛ T under ligand conditions L1 ; L2 ˛Ld
ueL1 L2 ˛ Bhdetermines if enzyme e˛E is produced under ligand conditions L1 ; L2 ˛Ld
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YeL1 L2 ˛ Bhbinary variable determining if the enzyme e˛E has sufficient
concentration to be considered active under ligand conditions L1 ; L2 ˛Ld
WeL1 L2 ˛ Bhbinary variable determining if enzyme e˛E is both at sufficient
concentration to be active and that it is not inhibited; in short that it will
function underligand conditions L1 ; L2 ˛Ld
keL1 L2 ˛ Bhbinary variable determining if enzyme ˛E is produced and can be
active under ligand conditions L1 ; L2 ˛Ld
ZD ˛ Rhobjective variable for EuGeneCiD
ZM ˛ Rhobjective variable for EuGeneCiM
Dee1 ˛ R + hdirect attribution of enzyme e activity to e1 through enzyme interactions
Kee1 ˛ R + hdirect attribution of enzyme e activity to e1 through enzyme e1 on triad
interactions
Uee1 e2 ˛ R + hattribution of enzyme e activity to e2 acting through e1 through
enzyme interactions
+
0
˛
R
hnetworked
attribution
of
enzyme e activity to e1 acting through other enzymes
Uee
1
reflecting direct enzyme  enzyme interactions
cee1 e2 ˛ R + hattribution of enzyme e activity to e2 acting through e1 through enzyme on
triad interactions
Xee1 ˛ R + hnetworked attribution of enzyme e activity to e1 acting through other enzymes
reflecting enzyme on triad interactions
Le ˛ Bhvalue of 1 if enzyme e is encoded by the genetic circuit design; 0 otherwise
bee1 ˛ Bhvalue of 1 if enzymes e and e1 are encoded by the genetic circuit design;
0 otherwise
EuGeneCiD problem statement and explanation
Objective function. Objective function (Equation 1)
X X X


maximize ZD =
CeL1 L2 leL1 L2  CeL1 L2 1  leL1 L2

(Equation 1)

e˛Ed L1 ˛Ld L2 ˛Ld

Where ZD is the objective value, CeL1 L2 is the contraction of enzyme e under conditions with signals L1 and L2
(which includes ‘‘none’’) and leL1 L2 is the desired phenotype in response to signals L1 and L2 as encoded in
the conceptualized logic table (this term is order-dependent). See the STAR Methods section for the full list
of symbols and their definitions. This equation, Equation (1), seeks to maximize the responses of the
desired enzymes under their desired conditions (in terms of concentration) and minimize the responses
of the undesired enzymes under their undesired condition.
Note that in the above equation, the order of set elements matters, e.g., CGFP;Zn2 + ;none is mathematically distinct
from CGFP;none;Zn2 + though efforts have been made to ensure that they will have the same value. Nonetheless,
the issue of combinations (of which there are a total of 8 for any given ligand set in this work, where the set includes the two ligands to which the system should respond as well as ‘‘none’’) affects the objective function.
From this, an AND circuit would only have 1 of 8 values of leL1 L2 with a 1 and the remainder would be 0. Similarly,
a NOR circuit would only have a single non-zero value in its order-dependent conceptualization matrix (leL1 L2 ).
This results in these circuits having unusually low objective values, as most terms are subtractive. The tendency in
optimal designs then is to strongly favor designs with minimal expression leakage. Conversely, OR and NAND
circuits have only one or two zero values in their order-dependent conceptualization matrix (leL1 L2 ), and therefore most terms are additive. Therefore, optimal circuit designs here tend to favor high inducible expression.
Therefore, in Figure 7, it is best to not compare objective function values between different conceptualizations,
but to only compare within conceptualizations. Depending on the tendencies of circuit design due to the circuit
type, more complex circuits could result in lower expression leakage or higher inducible expression, and these
complexities cannot be built into small circuits consisting of one or two triads.

Constraint equations
Circuit size limitations.

Circuit size limitations are defined in Equations 2, 3, 4, and 5.These equations

limit the number of:
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1) Maximum number of copies of a single promotor which can be used in the circuit design (Np;max ),
Equation (2).
2) Maximum number of copies of a single transcript which can be used in the circuit design (Nj;max ),
Equation (3).
3) Maximum number of copies of a single terminator which can be used in the circuit design (Nt;max ),
Equation (4).
4) Total number of promotors, transcripts, and terminator triads which the circuit design can use
(Ncircuit;max ), Equation (5).

XX

Mpjt %Np;max

c p˛P

(Equation 2)

Mpjt %Nj;max

c j˛J

(Equation 3)

XX
Mpjt %Nt;max

c t˛T

(Equation 4)

j˛J t˛T

XX
p˛P t˛T

p˛P j˛J

XXX
Mpjt %Ncircuit;max

(Equation 5)

j˛J p˛P t˛T

Note that by the nature of the variables used (e.g., Mpjt being binary), only one copy of any given triad may
be present in the designed circuit. However, any number of promotor/transcript, promotor/terminator, and
transcript/terminator pairs may be repeated. This is important to later constraints. It should be noted that
Ncircuit;max is set to 1 in the first attempt to solve EuGeneCiD and incremented by 1 each time no solution is
found or the problem is deemed infeasible. In this way, the simplest circuit designs possible are identified
and precluded from future solutions so that each solution is the simplest possible (Equations 2, 3, 4, and 5).

Promotor state under conditions. These equations determine if a promotor is active under the given
conditions of ligand 1 and/or/nor 2 being present. Equations perform as follows (Equations 6, 7, and 8):
1) Determines the net effect of (by term): i) promotor normal state, ii) activation or inhibition by enzymes
produced by the circuit, iii) inhibition or activation by ligand L1 , iv) inhibition or activation by ligand
L2 , v) prevent duplicate activation/inhibition if L1 and L2 . Equation (6).
+
+
= 1, and if apLd Ld1 %0 then apL
= 0. Equations (7) and (8).
2) Ensures that if apLd Ld1 >0then apL
1 L2
1 L2

apL1 L2 = Zp +

X
e˛E


WeL1 L2 Ipe Hpe + IpL1 HpL1 + IpL2 HpL2  IpL1 sL1 L2 HpL1




+
+
+ εapL
apL1 L2 R  V 1  apL
1 L2
1 L2
+
apL1 L2 %V apL
1 L2

c p˛P; L1 ; L2 ˛Ld

c p˛P; L1 ; L2 ˛Ld
c p˛P; L1 ; L2 ˛Ld

(Equation 6)
(Equation 7)
(Equation 8)

Transcription under conditions. These equations determine if and to what extent transcript j is intentionally transcribed from promotor p under ligand L1 and L2 conditions (xpjtL1 L2 ). The following equations
accomplish the following:
1) A transcript cannot be transcribed from a given promotor unless the promotor and transcript are
paired in the circuit design.
2) Transcription will not occur unless the promotor is ‘‘on’’.
+
3) All three constraints are equivalent to: xpjtLd Ld1 = Sp Mpjt apL
, Equations (9), (10), and (11).
1 L2

xpjtL1 L2 %Sp Mpjt
c p˛P; j˛J; t˛T; L1 ; L2 ˛Ld
+
xpjtL1 L2 %Sp apL
c
p˛P;
j˛J; t˛T; L1 ; L2 ˛Ld
1 L2


+
c p˛P; j˛J; t˛T; L1 ; L2 ˛Ld
xpjtL1 L2 RSp Mpjt + apL1 L2  1
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The following equations determine the transcript level (4jLd Ld1 ) as the sum of positive effects on the transcript level, including deliberate (xpjL1 L2 ) and leaky (Mpjt Fp ) transcription. This is scaled by a half-life-based
amount of RNA degradation to simulate the fact that degradation occurs and factors this into circuit design
(Equations 9, 10, 11, and 12).

0 
2
13
1
X 6
B
Gt + ε
C7
4jtL1 L2 =
4 xpjL1 L2 + Mpjt Fp @0:5
A5

c j˛J; t˛T; L1 ; L2 ˛Ld

(Equation 12)

p˛P

Translation under conditions. The following equation determines the enzyme concentration level
(CeLd Ld1 ) as the sum of effects on the enzyme concentration level (CeLd Ld1 ), Equation (17), reduced by a
half-life-based enzyme degradation multiplicative factor (Equations 13, 14, 15, 16, and 17).
CeL1 L2 =

X 
j˛J

rje hj 4jL1 L2




1

0:5Re + ε

c e˛E; L1 ; L2 ˛Ld

(Equation 13)

The following equations determine if the enzyme is being produced ueL1 L2 = 1 if produced and zero
otherwise.

ueL1 L2 %V CeL1 L2
ueL1 L2 RεCeL1 L2

c e˛E; L1 ; L2 ˛Ld
c e˛E; L1 ; L2 ˛Ld

(Equation 14)
(Equation 15)

The following equations, Equations (18) and (19), determine if the concentration of the enzyme is at suffi+
cient levels (qe ) to say that the enzyme could be active, CeL
= 1 if sufficient concentration, zero otherwise.
1 L2
+
ðqe + εÞCeL
%CeL1 L2
1 L2
+
CeL1 L2 %ðV  ðqe  εÞÞCeL1 L2 + ðqe  εÞ

c e˛E; L1 ; L2 ˛Ld
c e˛E; L1 ; L2 ˛Ld

(Equation 16)
(Equation 17)

Enzyme regulation and activity under conditions. Determine the net effect of ligands on the enzyme
(geLd Ld1 ) to determine if the protein is active or inactive due to the present ligands (deLd Ld1 , concentration incorporated through interaction strength QeLd1 ) (Equations 18, 19, 20, 21, 22, 23, 24, 25, 26, 27,
and 28).
1) Sum of the effects of present ligands and enzymes on the possibility of enzyme e being able to be
activated (geLd Ld1 ), Equation (18).
2) Determine net effect of activation/inhibition on the enzyme (deLd Ld1 ) Equations (19) and (20).

geL1 L2 = ze +

X


We1 L1 L2 Bee1 Qee1 + BeL1 QeL1 + BeL2 QeL2  BeL1 QeL1 sL1 L2

c e˛E; L1 ; L2 ˛Ld

e1 ˛E



+
+
geL1 L2 R  V 1  geL
+ εgeL
1 L2
1 L2
+
geL1 L2 %V geL
1 L2

(Equation 18)
c e˛E; L1 ; L2 ˛Ld
c e˛E; L1 ; L2 ˛Ld

(Equation 19)
(Equation 20)

Determine if the protein is both produced and can be active. These three constraints, Equations (21), (22),
and (23), are equivalent to keLd Ld1 = ueLd Ld1 deLd Ld1 (this works because all the variables are binary).

keL1 L2 %ueL1 L2
c e˛E; L1 ; L2 ˛Ld
+
keL1 L2 %geL
c
e˛E; L1 ; L2 ˛Ld
1 L2
+
keL1 L2 RueL1 L2 + geL

1
c e˛E; L1 ; L2 ˛Ld
1 L2

(Equation 21)
(Equation 22)
(Equation 23)

Determine if the protein is produced, active, and at sufficient concentration for it to function. These three
constraints, Equations (24), (25), and (26), are equivalent to WeLd Ld1 = keLd Ld1 YeLd Ld1 (this works because all the
variables are binary).

WeL1 L2 %keL1 L2
c e˛E; L1 ; L2 ˛Ld
+
WeL1 L2 %CeL
c e˛E; L1 ; L2 ˛Ld
L
1 2
+
WeL1 L2 RkeL1 L2 + CeL

1
c e˛E; L1 ; L2 ˛Ld
1 L2

(Equation 24)
(Equation 25)
(Equation 26)

Force the logic table to be true in Equation (27).
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W ed L1 L2 = led L1 L2

c ed ˛Ed ; L1 ; L2 ˛Ld

(Equation 27)

Attribution of enzyme activity to given conditions under conditions. Given all these equations, it is
not guaranteed that the circuit produced thus far will truly respond to the input ligands. One persistent
issue with the formulation to this point is that a Bistable Orthogonal Design (BOD) can be returned which
is independent of the input ligands and the optimization solver will simply choose the appropriate state to
appear to meet the logic table. This causes a circuit which appears to the solver to meet design criteria, but
in fact does not because it does not respond to ligand conditions. This issue is addressed through what we
are choosing to call the attribution constraints. These constraints are created to determine what changes
the activity of a protein in a given genetic circuit (e.g., what is the change attributable to?). This is done with
several stages of equations (Equations 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47,
48, 49, and 50).
Set 1: Determine if a particular enzyme pair is encoded. These equations are used to determine if a
particular enzyme is encoded (encoded in the binary Le ). This is important in that an enzyme has no attribution from other enzymes and is not attributable to other enzymes (Equations 28, 29, 30, 31, and 32).
XXX

Le Rε
Mpjt rje
p˛P j˛J t˛T

Le %V

XXX

Mpjt rje



c e˛E

(Equation 28)

c e˛E

(Equation 29)

p˛P j˛J t˛T

Note that this is formulated as such to allow for multiple transcript copies in a given circuit design. Next, a
determination is made as to whether enzyme pairs are encoded (encoded in the binary bee1 ); attribution
cannot exist between enzymes.

bee1 %Le
c e˛E
bee1 %Le1
c e1 ˛E
bee1 RLe + Le1 + 1
c e; e1 ˛E

(Equation 30)
(Equation 31)
(Equation 32)

Set 2: Determine if a particular enzyme affects another enzyme’s expression. Next, we determine the
effect of one enzyme upon the expression of another, through various means. First, through directly
affecting enzyme activity (effect of e1 upon e). Note that the variable Dee1 is restricted to be strictly nonnegative (Equations 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, and 47).
Dee1 = Bee1 bee1

c e; e1 ˛E

(Equation 33)

Note that the above is linear because Bee1 is a parameter. It was discovered during debugging procedures
that attempting to track the sign of attributions can lead to numerical issues (such as an attribution
canceling itself out, but still existing); therefore, only the fact of attribution is determined using absolute
values. The next group of equations determines the effect of e1 upon e through controlling the triad expressing e. Note that the variable Kee1 is restricted to be strictly non-negative.

Kee1 %

XX

"
Ipe1

Kee1 %V bee1
c e; e1 ˛E
#
X



Mpjt rje + V 1  bee1
c e; e1 ˛E

p˛P j˛J

t˛T

p˛P j˛J

t˛T

"
#
X
XX


Ipe1 
Mpjt rje  V 1  bee1
Kee1 R

(Equation 34)
(Equation 35)

c e; e1 ˛E

In combination with the domain of Kee1 , Kee1 = 0 if bee1 = 0, and Kee1 =

PP
p˛P j˛J

(Equation 36)
Ipe1 

P

t˛T

Mpjt rje otherwise.

Next, the effect of one enzyme (e2 ) upon another enzyme (e) through another enzyme (e1 ). This passing
of attribution might be through direct enzyme effects (Dee1 ) or through the effect of one enzyme upon
the triad of another (Kee1 ). The variable n0e1 e2 below is a binary variable noting if there is attribution of enzyme
e2 upon enzyme e1 (e.g., e2 in some way affects the activity of e1 ).

Uee1 e2 %V bee1
c e; e1 ; e2 ˛E


c e; e1 ; e2 ˛E
Uee1 e2 % Bee1 n0e1 e2 + V 1  bee1


0
c e; e1 ; e2 ˛E
Uee1 e2 R Bee1 ne1 e2  V 1  bee1
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0
This can then be condensed into the variable Uee
which removes the middle enzyme:
1
0
Uee
=
1

X



Uee2 e1 1  see1 se1 e2

c e; e1 ; e2 ˛E

e2 ˛E

(Equation 40)

0
Therefore, Uee
represents the indirect attribution of e1 to the activity of e through direct attributions. This
1
allows any number of intermediates between two enzymes to still count toward attribution due to the effects of networking. Note that the ð1 see1 se1 e2 Þ term prevents an enzyme attributing to itself through itself.
This prevents a potential self-referential problem which occurs with the definition of n0ee1 . It should be noted
0
that Uee
tracks only enzyme-enzyme interaction networks. Similarly, Xee1 will track enzyme attribution net1
works through effects on enzyme triads, though due to the need to track triads the formulation is neces0
sarily more complex. Together, Uee
and Xee1 allow for full networked tracking of attribution through any
1
number of intermediary enzymes and regulatory mechanisms.

cee1 pjt %

Xh

e2 ˛E

cee1 pjt R

Xh

e2 ˛E

Ipe2

cee1 pjt %V Mpjt
c e; e1 ˛E; p˛P; j˛J; t˛T
i


+ V 1  Mpjt
c e; e1 ˛E; p˛P; j˛J; t˛T

n0e2 e1 rje

i



Ipe2 n0e2 e1 rje  V 1  Mpjt
Xee1 =



XXXh
p˛P j˛J t˛T

c e; e1 ˛E; p˛P; j˛J; t˛T
i

cee1 pjt

c e; e1 ˛E

(Equation 41)
(Equation 42)
(Equation 43)
(Equation 44)

0
Now that the direct (Dee1 and Kee1 ) and networked (Uee
and Xee1 ) attribution variables have been deter1
mined, the total attribution can be determined.
0
nee1 = Dee1 + Kee1 + Uee
+ Xee1
1

c e; e1 ˛E

(Equation 45)

0
Note that nee1 is a nonnegative variable, since Dee1 , Kee1 , Uee
, and Xee1
1

are all nonnegative values which may
have values greater than 1 depending on the definitions of Ipa (for p˛P and a˛A) and Bea (for e˛ E and a˛ A).
For instance, in some cases it is useful to have values greater than 1 in Ipa or Bea to indicate that some effectors are stronger than others. Due to the need for referencing total attribution within the network attri0
bution variables (Uee
and Xee1 , which themselves are part of the total attribution) there arises an issue
1
related to the use of multiplication. If a value other than zero or one is used in calculating the total attribution’s effect on the network attribution variables, attributions which influence each other could quickly increase in magnitude through recursion. Another potential issue is the possibility that if total attributions are
not equal in magnitude, this could result in solution infeasibility as the two attributions cannot exist
together. Therefore, there is a need to transform the non-negative nee1 into the binary n0ee1 so that multiplicative identity Equations 38, 39, 42, and 43 might apply and bypass both these issues. Therefore, n0ee1 is a
binary which is determined using the following constraints.

nee1 Rn0ee1
nee1 %V n0ee1

c e; e1 ˛E
c e; e1 ˛E

(Equation 46)
(Equation 47)

Set 3: Preventing self-controlling enzymes. Now that attribution of one enzyme to another can be
determined (n0ee1 ), we have used this variable to prevent an enzyme from directly or indirectly controlling
its own expression (which can lead to BODs). This can be prevented by ensuring that there is no self-attribution (Equations 48 and 49).
n0ee1 Rsee1  1
n0ee1 %1  see1

c e; e1 ˛E
c e; e1 ˛E

(Equation 48)
(Equation 49)

Set 4: Prevent the addition of meaningless bioparts. The above equations prevent self-attribution and
BODs, but do not prevent the addition of meaningless triads to a solution. It was found during development that the addition of meaningless triads was one way for a solution to be reported again at larger circuit sizes. This can be relatively easily fixed with a single equation, which ensures that any encoded enzyme
affects circuit reporter enzymes (Equation 50).
Le %

Xh

ed ˛Ed

i
val
n0ed e + Ed;e

c e˛E

(Equation 50)

val
val
where Ed;e
= 1 if e is a member of the set Ed and Ed;e
= 0 otherwise. This ensures that each encoded enzyme
in some way influences the activity of at least one reporter enzyme or is itself a reporter enzyme.
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Speed boosting constraints. The following constraints should be implicitly true given all of the previous
constraints, yet it was discovered, as with the OptFill tool (Schroeder and Saha, 2020), that explicitly
defining implicit relationships can result in quicker solution times. The following relationship where explicitly defined (Equations 51, 52, 53, 54, 55, and 56):
1) Equation 51 ensures that all response enzymes are encoded in the genetic circuit.
2) Equations 52, 53, and 54 ensures that no enzyme has activity unless encoded in the genetic circuit.
3) Equations 55 and 56 ensure that no enzyme has concentration unless encoded in the genetic circuit.

val
Ed;e
%Le
WeL1 L2 %Le
keL1 L2 %Le
ueL1 L2 %Le
CeL1 L2 %Le
+
CeL
%Le
1 L2

c e˛E; L1 ; L2 ˛Ld
c e˛E; L1 ; L2 ˛Ld
c e˛E; L1 ; L2 ˛Ld
c e˛E; L1 ; L2 ˛Ld
c e˛E; L1 ; L2 ˛Ld
c e˛E; L1 ; L2 ˛Ld

(Equation
(Equation
(Equation
(Equation
(Equation
(Equation

51)
52)
53)
54)
55)
56)

EuGeneCiM problem statement and explanation. While the EuGeneCiM formulation is based upon
that of EuGeneCiD, it is markedly less complex due to three factors: i) the design is already known, so
Mpjt becomes a parameters as opposed to a variable; ii) the design is already complete, attribution
need not be tracked; and iii) the transcript an enzyme levels at the current time point are those produced
at previous time point(s) and EuGeneCiM is simply solving for the production rate of enzymes and transcripts for the current time point.
Objective function.

Objective function (Equation 57)

The selected objective function is to maximize the production of proteins

maximize ZM =

XX X

CeL1 L2



(Equation 57)

e˛E L1 ˛Ld L2 ˛Ld

Note that the objective function is largely unimportant however, as the constraint equations which follow
are generally equality constraints, some of which lack variables.

Constraint equations
Determining the level of transcript production.

The first set of constraint equations determine the level
of transcript production. First, the activity of the promotor under each condition set is evaluated in the
same manner as in EuGeneCiD (Equations 6, 7, and 8 and 58):

apL1 L2 = Zp +

X


WeL1 L2 Ipe Hpe + IpL1 HpL1 + IpL2 HpL2  IpL1 sL1 L2 HpL1

e˛E



apL1 L2 R  V 1 

+
apL
1 L2



+
+ εapL
1 L2

+
apL1 L2 %V apL
1 L2

c p˛P; L1 ; L2 ˛Ld

c p˛P; L1 ; L2 ˛Ld
c p˛P; L1 ; L2 ˛Ld

(Equation 6)
(Equation 7)
(Equation 8)

Then, the level of transcript production under each condition can be evaluated, similar to as is done in
Equations (9), (10), (11), and (12) with two distinct simplifications: i) as Mpjt is a parameter, the linearization
+
of Sp Mpjt apL
accomplished in Equations (9), (10), and (11)is no longer needed, and is substituted directly
1 L2
into Equation (12) and ii) degradation of RNA is handled in another programmatic step between the time
points, rather than at a single time point as in EuGeneCiD, therefore this is not included.
prod

4jtL1 L2 =

Xh
p˛P

+
Sp Mpjt apL
+ Mpjt Fp
1 L2

i

c j˛J; t˛T; L1 ; L2 ˛Ld

(Equation 58)

Note that the superscript prod is added to 4prod
jtL1 L2 to indicated that this is the transcript production at the
current time point. This is an important distinction as the transcript carried over from the previous time
n1
and is used to calculate the protein production at time tn . This arrangement allows
point is denoted 4tjtL
1 L2
for the simulation of the delay between triad activation and transcript production, as well as between
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transcript production and enzyme expression. Also, note that the identity of the terminator is tracked in
n
4tjtL
as the terminator determines the half-life of its associated transcript.
1 L2

Determining the level of protein production.

As mentioned, the amount of protein produced at time tn
is calculated from the amount of transcript carried over from the previous time point tn1 . This is calculated
in the following equation, which is analogous to Equation (13) without the degradation term (Equation 59).
prod

CeL1 L2 =

"
X

rje hj

j˛J

X t
4jtLn11 L2

#
c e˛E; L1 ; L2 ˛Ld

(Equation 59)

t˛T

prod
Note that CeL
represents to protein production at time tn , and that the activity of those proteins is deter1 L2
tn1
mined by the carry-over from the previous time point, CeL
.
1 L2
tn1
Determining the activity of the proteins. Using the carry-over protein concentration, CeL
, the activity
1 L2
of the enzyme is calculated in the same way as in EuGeneCiD and utilizing the same equations. These equations are restated here, see the symbols used section for symbol definitions (Equations 18, 19, 20, 21, 22, 23,
24, 25 and 26).

geL1 L2 = ze +

X


We1 L1 L2 Bee1 Qee1 + BeL1 QeL1 + BeL2 QeL2  BeL1 QeL1 sL1 L2

c e˛E; L1 ; L2 ˛Ld

e1 ˛E



geL1 L2 R  V 1 

+
geL
1 L2



(Equation 18)
+
+ εgeL
1 L2

c e˛E; L1 ; L2 ˛Ld

+
c e˛E; L1 ; L2 ˛Ld
geL1 L2 %V geL
1 L2
keL1 L2 %ueL1 L2
c e˛E; L1 ; L2 ˛Ld
+
keL1 L2 %geL
c e˛E; L1 ; L2 ˛Ld
1 L2
+
keL1 L2 RueL1 L2 + geL1 L2  1
c e˛E; L1 ; L2 ˛Ld
WeL1 L2 %keL1 L2
c e˛E; L1 ; L2 ˛Ld
+
WeL1 L2 %CeL
c e˛E; L1 ; L2 ˛Ld
1 L2
+
WeL1 L2 RkeL1 L2 + CeL

1
c e˛E; L1 ; L2 ˛Ld
L
1 2

(Equation 19)
(Equation
(Equation
(Equation
(Equation
(Equation
(Equation
(Equation

20)
21)
22)
23)
24)
25)
26)

Modeling degradation of transcripts and enzyme. Between time points, and attempted solutions of
EuGeneCiM, degradation of the bioparts are calculated as follows:

4tjtLn 1 L2 =

tn
CeL
1 L2



prod
4jtL1 L2

=



+ 4tjtLn11 L2

prod
CeL1 L2





0

B
@0:5

tn1
+ CeL
1 L2



0

1
1
Gt =1 + ε

C
A



B
@0:5

c j˛J; t˛T; L1 ; L2 ˛Ld

(Equation 60)

c e˛E; L1 ; L2 ˛Ld

(Equation 61)

1
1
Re =2 + ε

C
A

Note that there is one major difference in the degradation terms of Equations (60) and (61): the half-lives
are reduced by half in EuGeneCiM compared to EuGeneCiD. This in attempt to reconcile the differences
between EuGeneCiD and EuGeneCiM when considering the cumulative effects of dynamic modeling.
This occurs because, while EuGeneCiD accounts for a single time point and EuGeneCiM accounts for
several, the enzyme and transcript accumulations in EuGeneCiM were generally one or two order of
magnitude higher than that predicted in EuGeneCiD. This was an issue because the same concentration
thresholds existed for enzyme activity, and therefore resulted in no enzyme being in an ‘‘off’’ state after
sufficient time in EuGeneCiM. This fix reduces the half-life of transcripts and enzymes, resulting in closer
parity in concentration and modeling of circuit designs while minimizing the number of parameters
perturbed.

Other important aspects of EuGeneCiM formulation. Constraints not included in the formulation can
be as important as those which are and can serve to highlight the function of the problem. Specifically, no
constraints are included which force the provided conceptualization (in the form of a logic table) to be true.
This is for two reasons. The first is that, in solving in a point by point manner, there will inevitably be time
points in which the logic table is not true, particularly due to the delays between transcription and
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translation built into the tool. Secondly, this allows EuGeneCiM to be a screening process to remove any
designs which function differently when no longer optimizing for desired behavior or when considering dynamic behavior.

Designing and modeling genetic circuits
See Figure 4 for a visual representation of the overall workflow and to specifically illustrate how the EuGeneCiD
and EuGeneCiM formulations fit into this workflow. This work began with the conceptualization of synthetic
biology interventions. For the purposes of demonstrating these design and modeling tools, simple circuit conceptualizations were selected, namely the two input circuits of AND, NIMPLY, HALF ADDER, NAND, NOR,
XNOR, and XOR. Note that logic gates will be capitalized throughout this text to avoid confusion. These particular conceptualizations were chosen because they are easy to represent in logic table format, and well-known,
and often studied in the context of genetic circuits (particularly NOR and NIMPLY) (Borujeni et al., 2020) (Tan and
Ng, 2021). A library of bioparts (consisting of promotors, transcripts, terminators, and proteins) was then
selected which were i) native to Arabidopsis (particularly promotors), ii) demonstrated to be functional in synthetic biology applications in Arabidopsis, or iii) were from related plant species which we judged were likely
to function in synthetic biology applications. Note that when a particular biopart had different expression or
regulation patterns at different stages in growth or in different tissues, the pattern related to seedling root
was selected. These parts are described in detail in Table S2 These two items, conceptualizations and the
bioparts library, are then appropriately formatted as input files utilizing a Perl script (included in the associated
GitHub at github.com/ssbio/EuGeneCiDM) which reads a database file appended with the desired circuit logic,
example is provided in Table S3 with the full set used here in the associated GitHub at github.com/ssbio/
EuGeneCiDM), and writes the input files accordingly. EuGeneCiD was implemented in the Generalized Algebraic Modeling System (GAMS) language and run using the CPLEX solver. At this point, the workflow diverts
to several possible outcomes. First, EuGeneCiD found no designs of the appropriate size, indicated by no solution or an ‘‘integer infeasible’’ model status. This is addressed by incrementing the allowed model size by one,
provided the maximum allowable circuit design size has not been exceeded, and re-attempting to solve EuGeneCiD. The second possibility is that EuGeneCiD found a potential design which fits the current criteria. This
design will be the output of EuGeneCiD and the input of EuGeneCiM. EuGeneCiM then simulates the designed
circuit, beginning at time point zero with no initial concentration of any enzyme or transcript. EuGeneCiM will
return, as an output, the relative production of enzymes and transcripts at the given time point. The concentration of enzymes at the current time point is reduced according to the half-life characteristics of the enzyme or
transcript terminator, and the newly produced amount of each is added to this value as the carry over to the next
time point. EuGeneCiM is then solved for the next time point, and the process is repeated until all time points
have a solution. From this, the dynamic behavior of the designed circuit may be plotted as a visual representation of the circuit simulation. This can be done through an additional Perl script (included in the associated GitHub at github.com/ssbio/EuGeneCiDM). The cycle of design (through EuGeneCiD) and simulation (through
EuGeneCiM) continues until case two occurs. The final possible outcome of EuGeneCiD is that no designs of
the appropriate size can be found, and that incrementing the size would result in exceeding the maximum allowable circuit design size (here, ten triads). In this case, it will be concluded that there are no further designs, and
the design and simulation results should be manually screened to pick the most promising design candidate(s).
The example given here is a set of Cd/Cu responsive AND circuit from which is selected solution number 41,
which has the highest objective value.

Computing, language, and solving resources in implementation
This study has produced several unique software codes in the form of GAMS or Perl programming languages/tools. For implementing and solving EuGeneCiD and EuGeneCiM the Generalized Algebraic
Modeling System (GAMS), version 24.7.4 was used in conjunction with the CPLEX solver version 12.6.
Scripts which automate certain tasks utilize Perl version 5.26 for Unix or Strawberry Perl 5.24.0.1 for Windows. The code provided is compatible with both versions. The main workflow (previously described)
was implemented on the Holland Computing Center Crane Cluster and allowed to run for at most seven
days (168 hours) before being terminated. CPLEX solver settings used are included in the associated GitHub at github.com/ssbio/EuGeneCiDM.

QUANTIFICATION AND STATISTICAL ANALYSIS
Many values used in the definition of the bioparts in the database used were defined through manual quantification of quantitative data. For promotors, normal state was determined by literature evidence (either
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normally on or off). Strength and leakiness were determined, when possible, from western or northern blot
images, with strong expression being given a value of 5 and no expression being given a value of 1. In some
cases, the fold change in expression of a gene associated with a given promotor was known under induced
cases. In these cases, the ratio or strength to leakiness was adjusted to reflect these known expression
changes. Inducer and repressor identities were identified using literature evidence. The base strength of
induction or repression was set to 1; however, if some ligand showed greater activation or repression
than another, a value of 2 was assigned to model a greater effect on the activity of that particular promotor.
For transcripts, the transcriptional efficiency can represent various design elements of the gene, codon
optimization for instance, which can change the speed or efficiency of translation of the gene. A value of
0 would indicate that the gene cannot be translated and a value of 3 would indicate efficient translation.
In this work, there was no such adjusting of the translational properties of the genes; therefore, a base value
of 2 was assumed for all translational efficiencies. A small set of three terminators were identified from
Nagaya et al. (2010) and the relative half-lives of these terminators were determined as follows. The scale
used was from 0 representing near instant of mRNA to 3 representing slow degradation of associated
mRNA. Based on Nagaya et al. (2010) values of associated mRNA half-life for each terminator was quantified. For enzymes, the default state was determined from literature. The default expression and half-life
were assumed to be 5 and 2, respectively. These values were changed if literature evidence was found
to warrant the need to adjust these values. For instance, cI was noted as being rapidly degraded in registry
of standard biological parts, and therefore given a shorter half-life.

ADDITIONAL RESOURCES
This work accompanies a protocol paper for ease of replication, in addition to allowing others to utilize the
EuGeneCiD/S tools for their own studies. This protocol can be found in the journal STAR Protocols.

iScience 24, 103000, September 24, 2021

29

